PERCEPTIVE ADVISORS LLC

Q3 2022 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
116
Total value ($000)
$3,445,660
Net value change ($000)
+252,848 (7.9%)
New positions
16
Sold out positions
10
Turnover %
7.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/15/2022 Next filing: 2/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
RLMD 85,932 3729.7%
AMLX 85,850 125.9%
CinCor Pharma, Inc. 64,832 148.4%
Global Blood Therapeutics, Inc. 61,814 64.2%
BELLUS Health Inc. 57,073 111.6%
Cerevel Therapeutics Holdings, Inc. 49,528 36.8%
VRNA 39,369 322.3%
Prometheus Biosciences, Inc. 39,167 82.5%
Inhibrx, Inc. 30,106 138.5%
SRPT 27,967 NEW
Top Reduces (Value $000, Stocks/ETFs)
LLY -32,423 -100.0%
IOVA -32,381 -24.8%
NBIX -28,160 -72.6%
ALNY -25,231 -100.0%
PRCT -13,574 -55.4%
TVTX -11,577 -83.8%
CHRS -10,372 -39.3%
DAWN -9,953 -100.0%
RCKT -8,076 -50.3%
PRVA -7,962 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 5,240 (0.2% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type